Wong W, Singh A K
Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.
Curr Opin Nephrol Hypertens. 2001 Nov;10(6):807-11. doi: 10.1097/00041552-200111000-00012.
Many factors that drive glomerular and tubulointerstitial fibrogenesis have been identified. These include hemodynamic factors, chemokines, inflammatory mediators, cytokines, and lipids. These strides in knowledge are important in identifying those patients at increased risk of progressive renal disease as well as in developing targets for therapeutic interventions. Identifying 'progressors' is crucial since the distribution of the slope of the glomerular filtration rate of patients with chronic kidney disease is not normal. Some patients appear to progress very rapidly, such as those with diabetes, whereas other patients fail to progress at all. Developing strategies targeted at identifying the fast from the slow progressors is therefore of paramount importance if we are to deploy resources rationally in the management of patients with chronic kidney disease. The use of urinary cytokine markers as predictors of progression of renal disease is reviewed in this paper.
许多驱动肾小球和肾小管间质纤维化形成的因素已被确定。这些因素包括血流动力学因素、趋化因子、炎症介质、细胞因子和脂质。这些知识上的进展对于识别那些进展性肾病风险增加的患者以及开发治疗干预靶点具有重要意义。识别“进展者”至关重要,因为慢性肾病患者肾小球滤过率斜率的分布并不正常。一些患者进展非常迅速,如糖尿病患者,而其他患者则根本没有进展。因此,如果我们要在慢性肾病患者的管理中合理分配资源,制定针对区分快速进展者和缓慢进展者的策略至关重要。本文综述了尿细胞因子标志物作为肾病进展预测指标的应用。